Michael Collier is a Director of Lipid Nanoparticle Process Development with extensive experience in mRNA and lipid nanoparticle technologies. They have served as Associate Director of mRNA Process Development at Moderna from 2022 to 2024 and previously held various roles at the company, including Senior Engineer II and Principal Engineer. Michael earned two Doctorates in Molecular, Cellular, and Developmental Biology and Pharmacoengineering and Molecular Pharmaceutics from The Ohio State University and the University of North Carolina at Chapel Hill, respectively. Additionally, they hold a Bachelor's degree in Bioengineering and Biomedical Engineering from Clemson University.
This person is not in any teams
This person is not in any offices